QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension

International Journal of Cardiology

Volumn 167, Issue 3, 2013, Pages 669-676

  Rich, Jonathan D ^a   Thenappan, Thenappan ^a   Freed, Benjamin ^a   Patel, Amit R ^a   Thisted, Ronald A ^a   Childers, Rory ^a   Archer, Stephen L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Biomarkers; Brain natriuretic peptide; Cardiac repolarization; Pulmonary hypertension; Right ventricular failure; Right ventricular hypertrophy

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; POTASSIUM; POTASSIUM CHANNEL; PROSTACYCLIN; PROSTANOID;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART INDEX; HEART OUTPUT; HEART REPOLARIZATION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POTASSIUM BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; SURVIVAL RATE;

BIOMARKERS; BRAIN NATRIURETIC PEPTIDE; CARDIAC MAGNETIC RESONANCE IMAGING; CARDIAC REPOLARIZATION; CMR; ECG; ELECTROCARDIOGRAM; LEFT VENTRICULAR HYPERTROPHY; LVH; N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; NT-PROBNP; PAH; PAP; PULMONARY ARTERIAL HYPERTENSION; PULMONARY ARTERY PRESSURE; PULMONARY HYPERTENSION; PULMONARY VASCULAR RESISTANCE; PVR; QT INTERVAL CORRECTED FOR HEART RATE; QTC; RIGHT VENTRICLE; RIGHT VENTRICULAR EJECTION FRACTION; RIGHT VENTRICULAR END-DIASTOLIC VOLUME; RIGHT VENTRICULAR END-SYSTOLIC VOLUME; RIGHT VENTRICULAR FAILURE; RIGHT VENTRICULAR HYPERTROPHY; RV; RVEDV; RVEF; RVESV; WHO; WORLD HEALTH ORGANIZATION;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; LONG QT SYNDROME; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84880923973     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.071     Document Type: Article

References (37)

1. N. Galie, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
2. V.V. McLaughlin, S.L. Archer, and D.B. Badesch ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 2009 1573 1619
3. T. Thenappan, S.J. Shah, S. Rich, L. Tian, S.L. Archer, and M. Gomberg-Maitland Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation Eur Respir J 35 2010 1079 1087
4. F. Haddad, R. Doyle, D.J. Murphy, and S.A. Hunt Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure Circulation 117 2008 1717 1731
5. S.A. van Wolferen, J.T. Marcus, and A. Boonstra Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension Eur Heart J 28 2007 1250 1257
6. L. Abenhaim, Y. Moride, and F. Brenot Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group N Engl J Med 335 1996 609 616
7. G.S. Ahearn, V.F. Tapson, A. Rebeiz, and J.C. Greenfield Jr. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease Chest 122 2002 524 527
8. J. Lehtonen, S. Sutinen, M. Ikaheimo, and P. Paakko Electrocardiographic criteria for the diagnosis of right ventricular hypertrophy verified at autopsy Chest 93 1988 839 842
9. L. Piao, Y.H. Fang, and V.J. Cadete The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle J Mol Med 88 2010 47 60
10. F. Akgul, E. Seyfeli, and I. Melek Increased QT dispersion in sickle cell disease: effect of pulmonary hypertension Acta Haematol 118 2007 1 6
11. Z. Hong-liang, L. Qin, and L. Zhi-hong Heart rate-corrected QT interval and QT dispersion in patients with pulmonary hypertension Wien Klin Wochenschr 121 2009 330 333
12. Healthcare G. Marquette 12SL ECG analysis program physicians' guide 2007
13. S. Talbot QT interval in right and left bundle-branch block Br Heart J 35 1973 288 291
14. N. Nagaya, T. Nishikimi, and M. Uematsu Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension Circulation 102 2000 865 870
15. E.F. Schisterman, and B.W. Whitcomb Use of the social security administration death master file for ascertainment of mortality status Popul Health Metr. 2 2004 2
16. F. Parent, D. Bachir, and J. Inamo A hemodynamic study of pulmonary hypertension in sickle cell disease N Engl J Med 365 2011 44 53
17. S. Luo, K. Michler, P. Johnston, and P.W. Macfarlane A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs J Electrocardiol 37 2004 81 90 Suppl.
18. A.P. Kalogeropoulos, V.V. Georgiopoulou, and S. Howell Evaluation of right intraventricular dyssynchrony by two-dimensional strain echocardiography in patients with pulmonary arterial hypertension J Am Soc Echocardiogr 21 2008 1028 1034
19. H.J. Shenkman, V. Pampati, and A.K. Khandelwal Congestive heart failure and QRS duration: establishing prognosis study Chest 122 2002 528 534
20. V. Hombach, N. Merkle, and J. Torzewski Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy Eur Heart J 30 2009 2011 2018
21. S. Iuliano, S.G. Fisher, P.E. Karasik, R.D. Fletcher, and S.N. Singh QRS duration and mortality in patients with congestive heart failure Am Heart J 143 2002 1085 1091
22. L. Oikarinen, M.S. Nieminen, and M. Viitasalo QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan intervention for endpoint reduction in hypertension study Hypertension 43 2004 1029 1034
23. K.S. Spargias, S.J. Lindsay, and G.I. Kawar QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure Eur Heart J 20 1999 1158 1165
24. B. Vrtovec, R. Delgado, A. Zewail, C.D. Thomas, B.M. Richartz, and B. Radovancevic Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure Circulation 107 2003 1764 1769
25. P.R. Kowey, T.D. Friechling, and J. Sewter Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade Circulation 83 1991 2067 2075
26. S.J. Rials, Y. Wu, and N. Ford Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart Circulation 91 1995 426 430
27. R. Fischer, R. Dechend, and A. Gapelyuk Angiotensin II-induced sudden arrhythmic death and electrical remodeling Am J Physiol Heart Circ Physiol 293 2007 H1242 H1253
28. G.E. D'Alonzo, R.J. Barst, and S.M. Ayres Survival in patients with primary pulmonary hypertension. Results from a national prospective registry Ann Intern Med 115 1991 343 349
29. M.M. Hoeper, N. Galie, and S. Murali Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension Am J Respir Crit Care Med 165 2002 341 344
30. A. Gomez, D. Bialostozky, and A. Zajarias Right ventricular ischemia in patients with primary pulmonary hypertension J Am Coll Cardiol 38 2001 1137 1142
31. S.A. van Wolferen, J.T. Marcus, and N. Westerhof Right coronary artery flow impairment in patients with pulmonary hypertension Eur Heart J 29 2008 120 127
32. H.J. Bogaard, R. Natarajan, and S.C. Henderson Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure Circulation 120 2009 1951 1960
33. G.J. Vlahakes, K. Turley, and J.I. Hoffman The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations Circulation 63 1981 87 95
34. S. Zhou, J.M. Cao, and Z.D. Tebb Modulation of QT interval by cardiac sympathetic nerve sprouting and the mechanisms of ventricular arrhythmia in a canine model of sudden cardiac death J Cardiovasc Electrophysiol 12 2001 1068 1073
35. M. Nootens, E. Kaufmann, and T. Rector Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels J Am Coll Cardiol 26 1995 1581 1585
36. R.W. Schrier, and S. Bansal Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol 3 2008 1232 1237
37. S. Rich, J. Pogoriler, A.N. Husain, P.T. Toth, M. Gomberg-Maitland, and S.L. Archer Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension Chest 138 2010 1234 1239